Angela Merkel in talks to bring Russian Covid-19 vaccine to EU
German chancellor and Vladimir Putin discuss joint production of jab as criticism of Berlin’s vaccinations rollout intensifies
Angela Merkel has told Vladimir Putin that she is “open to the idea” of producing Russia’s Sputnik V vaccine in the EU as part of efforts to tackle widespread shortages across the continent.
Following talks between the German chancellor and Russian president, the Kremlin issued a statement saying that “issues of cooperation in combating the coronavirus pandemic were discussed, with an emphasis on possible prospects for joint production of vaccines”, Politico reports.
A spokesperson for Merkel confirmed that the chancellor had told Putin “that she is open to the idea of bilateral cooperation for the purpose of tapping European production capacities [for the Russian vaccine]”. The spokesperson added that the proposal was dependent on the European Medicines Agency giving its approval to the Sputnik V vaccine.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The talks, conducted by phone on Tuesday, come amid allegations that Germany has “bungled” the rollout of a Covid-19 vaccine, says Bloomberg.
Among those who have challenged Merkel’s strategy of ceding responsibility for procuring vaccines to the EU is Olaf Scholz, a senior member of the left-wing Social Democratic Party of Germany (SPD) and potential candidate for chancellor in September’s elections.
During a tense cabinet meeting, Scholz “presented Jens Spahn, the health minister and a member of Mrs Merkel’s Christian Democrats (CDU), with a four-page list of questions about his handling of the affair”, The Telegraph reports.
“This is about a very serious issue, whether we can properly protect the citizens of this country,” Scholz later told German television.
The row is a “clear signal that political manoeuvring has begun” ahead of federal elections later this year, says the newspaper. “But it is also a sign that the fall-out from the vaccine debacle threatens to engulf Mrs Merkel, who until now has been widely praised for her response to the virus.”
A total of 5.3 million doses of the Pfizer/BioNTech vaccine are due to be delivered to Germany by mid-February, with a further 667,000 doses due every week from the end of January.
However, this tally would still leave Germany far short of the number of doses needed to vaccinate the population, amid rising infection rates and deaths.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Saint Paul de Vence: a paradise for art lovers
The Week Recommends The hilltop gem in the French Riviera where 20th century modernism flourished
By Alexandra Zagalsky Published
-
'People in general want workers to earn a decent living'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
What might a Trump victory mean for the global economy?
Today's Big Question A second term in office for the 'America First' administration would send shockwaves far beyond the United States' shores
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published